Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients

Pharmacogenomics. 2024;25(8-9):357-365. doi: 10.1080/14622416.2024.2375190. Epub 2024 Jul 29.

Abstract

Background: Hypertension is a prevalent health concern in Indonesia, with a high percentage of patients unresponsive to ACE inhibitor treatment. Methods: This multicenter case-control study investigated the correlation between ACE I/D and captopril effectiveness in Indonesian hypertensive patients. Hypertensive patients were divided into control (n = 69) and case (n = 73) groups. ACE I/D was identified using PCR and electrophoresis.Results: No significant differences in genotype frequencies or allele distribution were observed. The difference of blood pressure reduction among the three genotypes also lacked statistical significance.Conclusion: ACE I/D is not significantly associated with blood pressure reduction following captopril therapy in Indonesian hypertensive patients. These results underscore the limited predictive utility of ACE I/D in managing hypertension with captopril.

Keywords: ACE I/D polymorphism; angiotensin-converting enzyme; captopril; hypertension; therapeutic effectiveness.

Plain language summary

[Box: see text].

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Blood Pressure / genetics
  • Captopril* / therapeutic use
  • Case-Control Studies
  • Female
  • Gene Frequency / genetics
  • Genotype
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / genetics
  • INDEL Mutation / genetics
  • Indonesia
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A* / genetics
  • Polymorphism, Genetic / genetics

Substances

  • ACE protein, human
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Captopril
  • Peptidyl-Dipeptidase A